As temperatures drop and leaves turn golden, health experts are warning of a familiar seasonal threat: respiratory viruses. The U.S. Centers for Disease Control...
Affordable access to lenacapavir
A twice-yearly HIV prevention injection, lenacapavir, will soon be available for just $40 per patient per year in 120 low- and...
Modest advances with new drugs
After decades of stalled progress, two treatments — Eli Lilly’s donanemab and Biogen and Eisai’s lecanemab — have shown the...